Ischemic tolerance modulates TRAIL expression and its receptors and generates a neuroprotected phenotype

Cell Death and Disease

Volumn 5, Issue 7, 2014, Pages

  Cantarella, G ^a   Pignataro, G ^b   Di Benedetto, G ^a   Anzilotti, S ^c   Vinciguerra, A ^b   Cuomo, O ^b   Di Renzo, G F ^b   Parenti, C ^d   Annunziato, L ^b,c   Bernardini, R ^a  

^a Pharmacology Section   (Italy)

^b Division of Pharmacology Department of Neuroscience Reproductive and Odontostomatologic Sciences   (Italy)

^c IRCCS SDN   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; DECOY RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; IMMUNOFLUORESCENCE; ISCHEMIC PRECONDITIONING; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPERFUSION; ANIMAL; BRAIN ISCHEMIA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN ISCHEMIA; GENE EXPRESSION REGULATION; HUMANS; ISCHEMIC PRECONDITIONING; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84905508821     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.286     Document Type: Article

References (43)

1. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415
2. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371: 1612-1623
3. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007; 20: 334-342
4. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006; 7: 437-448
5. Nakajima T, Iwabuchi S, Miyazaki H, Okuma Y, Kuwabara M, Nomura Y et al. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J Vet Med Sci 2004; 66: 521-527
6. Kariko K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 2004; 24: 1288-1304
7. Ceulemans A-G, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation 2010; 7: 74
8. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19: 819-834
9. Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147(Suppl 1): S232-S240
10. Cantarella G, Risuglia N, Lombardo G, Lempereur L, Nicoletti F, Memo M et al. Protective effects of estradiol on TRAIL-induced apoptosis in a human oligodendrocytic cell line: evidence for multiple sites of interactions. Cell Death Differ 2004; 11: 503-511
11. Cantarella G, Lempereur L, D'Alcamo MA, Risuglia N, Cardile V, Pennisi G et al. Trail interacts redundantly with nitric oxide in rat astrocytes: potential contribution to neurodegenerative processes. J Neuroimmunol 2007; 182: 41-47
12. Cantarella G, Uberti D, Carsana T, Lombardo G, Bernardini R, Memo M. Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity. Cell Death Differ 2003; 10: 134-141
13. Wang J, Shen J, Gao Q, Ye Z, Yang S, Liang H et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke J Cereb Circ 2008; 39: 983-990
14. Sheikh MS, Fornace AJ Jr. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000; 14: 1509-1513
15. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997; 277: 815-818
16. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 1997; 16: 5386-5397
17. Cui M, Wang L, Liang X, Ma X, Liu Y, Yang M et al. Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia. Neurobiol Dis 2010; 39: 138-147
18. Huang Z, Song L, Wang C, Liu J-Q, Chen C. Hypoxia-ischemia upregulates TRAIL and TRAIL receptors in the immature rat brain. Dev Neurosci 2011; 33: 519-530
19. Panneerselvam M, Patel PM, Roth DM, Kidd MW, Chin-Lee B, Head BP et al. Role of decoy molecules in neuronal ischemic preconditioning. Life Sci 2011; 88: 670-674
20. Cantarella G, Di Benedetto G, Scollo M, Paterniti I, Cuzzocrea S, Bosco P et al. Neutralization of tumor necrosis factor-related apoptosis-inducing ligand reduces spinal cord injury damage in mice. Neuropsychopharmacology 2010; 35: 1302-1314
21. Park S-Y, Billiar TR, Seol D-W. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Biophys Res Commun 2002; 291: 150-153
22. Cantarella G, Di Benedetto G, Pezzino S, Risuglia N, Bernardini R. TRAIL-related neurotoxicity implies interaction with the Wnt pathway in human neuronal cells in vitro. J Neurochem 2008; 105: 1915-1923
23. Cantarella G, Di Benedetto G, Martinez G, Loreto C, Clementi G, Cantarella A et al. Amylin prevents TRAIL-mediated apoptotic effects of reserpine in the rat gastric mucosa. Peptides 2009; 30: 1466-1472
24. Sancilio S, Di Giacomo V, Quaglietta AM, Iacone A, Angelucci D, Tatasciore U et al. TRAIL promotes a pro-survival signal in erythropoietin- deprived human erythroblasts through the activation of an NF-kB/IkBalpha pathway. J Biol Regul Homeost Agents 2011; 25: 375-386
25. LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 2003; 10: 66-75
26. Crowder RN, El-Deiry WS. Caspase-8 regulation of TRAIL-mediated cell death. Exp Oncol 2012; 34: 160-164
27. Fu L, Lin Y-D, Elrod HA, Yue P, Oh Y, Li B et al. c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Mol Cancer 2010; 9: 315
28. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J et al. CD95 ligand (Fas-L/APO-1 L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 1999; 19: 3809-3817
29. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 2002; 277: 29355-29358
30. Croft M, Benedict CA, Ware CF. Clinical targeting of the TNF and TNFR superfamilies. Nat Rev Drug Discov 2013; 12: 147-168
31. Lanzillotta A, Pignataro G, Branca C, Cuomo O, Sarnico I, Benarese M et al. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. Neurobiol Dis 2012; 49: 177-189
32. Valsecchi V, Pignataro G, Del Prete A, Sirabella R, Matrone C, Boscia F et al. NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke J Cereb Circ 2011; 42: 754-763
33. Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 1997; 7: 813-820
34. Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G et al. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J Immunol 2008; 181: 1001-1011
35. Mendoza FJ, Ishdorj G, Hu X, Gibson SB. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Apoptosis 2008; 13: 756-770
36. Chen J-J, Chou C-W, Chang Y-F, Chen C-C. Proteasome inhibitors enhance TRAILinduced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation. J Immunol 2008; 180: 8030-8039
37. Pei G-T, Wu C-W, Lin W-W. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. Biochem Biophys Res Commun 2010; 391: 1274-1279
38. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z et al. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 2008; 28: 232-241
39. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition. Academic Press: New York, 2007
40. Pignataro G, Gala R, Cuomo O, Tortiglione A, Giaccio L, Castaldo P et al. Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke 2004; 35: 2566-2570
41. Pignataro G, Boscia F, Esposito E, Sirabella R, Cuomo O, Vinciguerra A et al. NCX1 and NCX3: two new effectors of delayed preconditioning in brain ischemia. Neurobiol Dis 2012; 45: 616-623
42. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
43. Pignataro G, Esposito E, Cuomo O, Sirabella R, Boscia F, Guida N et al. The NCX3 isoform of the Na+/Ca2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning. J Cereb Blood Flow Metab 2011; 31: 362-370.